Kenneth Der, BS

Horizon Therapeutics
Danville, CA, United States

Associate Director, Clinical Pharmacology

Presentation(s):

• 1379: Population Pharmacokinetic/Pharmacodynamic Modeling of Dazodalibep, a CD40L Antagonist, in Healthy Volunteers and Patients with Rheumatoid Arthritis and Sjogren’s Syndrome

  Monday, November 13, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.